Biotech
Messing Around With the Warburg Effect
Publication: AAAS: Keyword search for query
Author: Not available in collected metadata
Source published: 28/10/2026, 02:30:21 UTC
Briefing created: 09/11/2026, 03:54:02 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 28/10/2026, 18:49:29 UTC.
Briefings
Researchers discovered that artificially boosting mitochondrial pyruvate production reverses the Warburg effect, slowing melanoma growth and suppressing tumor genes. This suggests mitochondria can inhibit cancer proliferation, challenging the view that the Warburg effect solely drives malignancy. The study uses a bacterial enzyme to restore pyruvate levels in HeLa cells, revealing a feedback loop where mitochondrial activity dampens tumor progression.
Key points
- Engineered cells expressing a Pseudomonas dehydrogenase restore mitochondrial pyruvate levels, reversing the Warburg effect and slowing melanoma growth.
- Suppressed tumor genes indicate mitochondria inhibit cancer proliferation, suggesting a feedback loop where mitochondrial activity dampens tumor progression.
Context
This research challenges the long-held view that the Warburg effect solely drives cancer. By restoring mitochondrial pyruvate, the study reveals mitochondria can inhibit tumor growth, offering new therapeutic targets beyond glucose uptake.
Limitations
The study focuses on HeLa cells and melanoma lines; extracellular pyruvate transport pathways remain unknown. Results are preliminary and may not apply to all cancer types.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 09/11/2026, 03:54:02 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeiecocmlojckv6mnmsrjheyg3lyn6sup2xwrq3s33rs3raq3j6coxi